Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Laboratorios Beta S.A.
Legal Form: Limited Liability Partnership
Operational Status: Operational
Incorporation Date: 07-May-54
anti-inflammatory and anti-rheumatic
Beta Labs, started its activities in Buenos Aires in the early 40s. He is currently the sole producer of insulin and transdermal delivery systems of the country and one of the few in the world who specialize in these technologies. In addition, Beta Labs is one of the largest producers of anti-inflammatory and anti-rheumaticMore
|Company Tear Sheet|
|NAICS Industry Classification||✓|
|Share Price information||✕|
|Subsidiaries and Affiliates||✕|
|Key Financial Highlights||✕|
|Financial Performance Charts||✕|
|Latest M&A and ECM Deals||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.